ALNY Down Despite Positive Data From Heart Disease Drug Study
ZacksAlnylam presents detailed data from the HELIOS-B study, seeking to expand Amvuttra’s label to include the treatment of ATTR amyloidosis with cardiomyopathy.
Alnylam presents detailed data from the HELIOS-B study, seeking to expand Amvuttra’s label to include the treatment of ATTR amyloidosis with cardiomyopathy.